Management of NMIBC during BCG shortage and COVID ‐19

Shortages of Bacille Calmette-Guerin (BCG) have implications for the management of patients with non-muscle-invasive bladder cancers Further complications come as a result of COVID-19 for which BCG also shows some promising prospects